2012-11-21 02:06:34 -
Cell-based Assays: Technologies and Global Markets - a new market research report on companiesandmarkets.com
Cell biology is currently the biggest revenue contributor to the life-science tools industry, accounting for approximately 30% of total sales. It is expected to grow to a $15 billion market by 2015, increasing at a compound annual growth rate (CAGR) of 12.3% from its 2010 value of $8.5 billion.The global market for cell-based assays for drug discovery for validating drug targets/lead profiling assays was valued at $6.2 billion in 2010. This sector is projected to increase at an 11.6% compound annual growth rate (CAGR) to reach nearly $10.8 billion in 2015.The absorption, distribution, metabolism, and excretion (ADME) testing sector was worth $1.5 billion in 2010 and is expected to reach $3 billion by 2015, a compound annual growth rate
(CAGR) of 15%.This market research report, Cell-Based Assays: Technologies and Global Markets, provides a detailed overview and thorough analysis of the present and future global market for cell-based techniques. This report analyzes in detail the cell-based assays available and currently used and their markets. This report includes products in this market and detailed analyses of markets and competitive environments, cell assays markets in newly emerging regions, and instrumentation and robotics and their impact on the market. The report includes information about significant products and assays, key players, issues and trends, current market status of cell-based assays, strengths, weaknesses, opportunities, and threats facing various assays and developments already on the market, major issues involved in the research and development (R&D) of more effective cell-based approaches, for drug discovery, and absorption, distribution, metabolism, and excretion (ADME)/ toxicity assays in development and in use.Cell-Based assays have emerged as a more relevant alternative to biochemical assays involving the use of purified proteins. Witnessing the growth in demand for cell-Based assays, a number of cell culture and liquid-handling instruments available on the market now allow cell-based screening. The majority of compound screening programs performed by the biopharmaceutical industry rely on cell-based assays for functional measures of target activation. Label-free cellular assays are driving this paradigm forward, with their sensitivity, robustness, ease of use, and flexibility. These assays are now performed routinely throughout early drug discovery from target identification and validation to primary screening, lead identification, and lead optimization and into safety and toxicology. There is a need to understand the trends in this market, currently available assays, and latest developments for drug discovery.The proposed report will give an update on Cell-Based Assays: Technologies and Global Markets. It will review global markets for cell-based assays and new developments and will forecast trends for use of these assays for drug discovery and safety and toxicology through 2015. Important assays, technologies and latest developments, market share by assay type, products on the market and market share by company, and statistical information for types of cancers prevalent worldwide, with special emphasis on the U.S. market. The report also includes current issues and trends affecting the industry and costs, and factors influencing demand will be discussed. The report covers products in development, new technologies, trends, alliances, and mergers. The report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints, and opportunities.This report is an exhaustive study on the worldwide cell-based assays market, giving crucial statistics and analysis on existing technologies, latest trends, market structure, market size, key drug segments, important trends in technology development, major opportunities, and market shares of key players and drugs. This report may prove crucial for the firms or investors seeking investments in the concerned sector. This report shows cell-based assays currently being used, new developments, spending trends, and revenue prospects for cell-based assays in pharma. The report provides market data for 2009 to 2015 and also covers commercial prospects for cell assays in drug research and ADME/toxicity assays.Chapters from this report can be purchased separately. Please contact us to find out more about this offer.
Click for report details:
www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports
www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports
www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports
www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.
